Access cutting-edge perennial allergic rhinitis treatment through this clinical trial at a research site in Inglewood. Study-provided care at no cost to qualified participants.
Access perennial allergic rhinitis specialists in Inglewood at no cost
This study follows strict safety protocols and ethical guidelines
All study-related perennial allergic rhinitis treatment provided free
The main purpose of this study is to evaluate the efficacy and safety of lebrikizumab in adult participants with perennial allergic rhinitis. Participants can expect study participation to last up to 29.5 months.
Sponsor: Eli Lilly and Company
Check if you qualify for this perennial allergic rhinitis clinical trial in Inglewood, CA
If you're searching for perennial allergic rhinitis treatment options in Inglewood, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Inglewood research site is actively enrolling participants for this clinical trial. You'll receive care from experienced perennial allergic rhinitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.